Angle Health Secures $200M Series C and $400M Tender Offer at $2.7B Valuation

Health insurance startup Angle Health has announced a major financial milestone on Friday, securing a $200 million Series C funding round alongside a massive $400 million tender offer. This substantial financial maneuver has propelled the company's overall valuation to an impressive $2.7 billion, reflecting strong investor confidence in its business model.

The financing round was officially led by Vitruvian Partners. Their investment was supported by a strong roster of returning and participating backers, including Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and startup accelerator Y Combinator.

Angle Health has deep ties to the startup ecosystem as a winter 2020 alumnus of Y Combinator. The company specializes in helping small businesses efficiently obtain and manage level-funded health plans, streamlining a historically complex and frustrating administrative process for employers and employees alike.

Amid broader economic shifts across the technology and healthcare sectors, Angle Health has managed to distinguish itself through solid financial fundamentals. The startup confirmed that it is currently profitable, a notable achievement for a growth-stage company in the insurtech space.

With its newly acquired capital from the Series C round and the $400 million tender offer, Angle Health is well-positioned to continue scaling its operations. The company currently serves over 5,000 businesses, providing them with modern health insurance solutions tailored to their specific organizational needs.